Abstract:
Based on the literature data, we present current literature information about frequency, main spectrum, and prognostic
value of cardiovascular complications of the SARS-CoV-2 infection. We have highlighted in detail the variants of
cardiovascular disorders in the case of patients with SARS-CoV-2 infection caused by concomitant diseases of
hypertension, acute coronary syndrome, myocardial infarction, arrhythmias, virus-associated myocarditis, and
heart failure. We have described the adverse cardiovascular effects of medicines of different groups used to treat
COVID-19 disease and possible medical interactions. We have summarized some current recommendations on
cardiotonic and cardioprotective therapy in the case of patients with cardiovascular complications.
